Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2310-2317

  Oizumi, Satoshi ^a   Strbo, Natasa ^a   Pahwa, Savita ^a   Deyev, Vadim ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN GP69; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; B7 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; PEPTIDE; SARCOMA GLYCOPROTEIN GP96 REJECTION ANTIGENS; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; CROSS REACTION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOMA; METABOLISM; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD4; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, NEOPLASM; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CROSS REACTIONS; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOMA; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; PEPTIDES; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VIRUS DISEASES;

EID: 34848885422     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2310     Document Type: Article

References (44)

1. Bevan, M. J. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117: 2233-2238.
2. + T cells: cross-priming in infectious diseases. Curr. Opin. Immunol. 13: 437-441.
3. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684.
4. Melief, C. J. 2003. Mini-review: regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur. J. Immunol. 33: 2645-2654.
5. Moron, G., G. Dadaglio, and C. Leclerc. 2004. New tools for antigen delivery to the MHC class I pathway. Trends Immunol. 25: 92-97.
6. Zanetti, M., P. Castiglioni, S. Schoenberger, and M. Gerloni. 2003. The role of relB in regulating the adaptive immune response. Ann. NY Acad. Sci. 987: 249-257.
7. + T cells. Nat. Immunol. 6: 593-599.
8. + T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
9. Serna, A., M. C. Ramirez, A. Soukhanova, and L. J. Sigal. 2003. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171: 5668-5672.
10. Shen, L., and K. L. Rock. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101: 3035-3040.
11. + T cells in vivo. Proc. Natl. Acad. Sci. USA 91: 3077-3081.
12. Udono, H., and P. K. Srivastava. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178: 1391-1396.
13. Li, Z., and P. K. Srivastava. 1993. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J. 12: 3143-3151.
14. Srivastava, P. K., and M. Heike. 1991. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin. Immunol. 3: 57-64.
15. Arnold, D., S. Faath, H. Rammensee, and H. Schild. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182: 885-889.
16. Binder, R. J., D. K. Han, and P. K. Srivastava. 2000. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1: 151-155.
17. Theriault, J. R., S. S. Mambula, T. Sawamura, M. A. Stevenson, and S. K. Calderwood. 2005. Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett. 579: 1951-1960.
18. Delneste, Y., G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
19. Blachere, N. E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186: 1315-1322.
20. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1588.
21. Arnold-Schild, D., D. Hanau, D. Spehner, C. Schmid, H. G. Rammensee, H. de la Salle, and H. Schild. 1999. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol. 162: 3757-3760.
22. Singh-Jasuja, H., H. U. Scherer, N. Hilf, D. Arnold-Schild, H. G. Rammensee, R. E. Toes, and H. Schild. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30: 2211-2215.
23. Vabulas, R. M., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C. J. Kirschning, C. Da Costa, H. G. Rammensee, H. Wagner, and H. Schild. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277: 20847-20853.
24. Ramirez, S. R., H. Singh-Jasuja, T. Warger, S. Braedel-Ruoff, N. Hilf, K. Wiemann, H. G. Rammensee, and H. Schild. 2005. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response. Cell Stress Chaperones 10: 221-229.
25. Strbo, N., S. Oizumi, V. Sotosek-Tokmadzic, and E. R. Podack. 2003. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18: 381-390.
26. Yamazaki, K., T. Nguyen, and E. R. Podack. 1999. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J. Immunol. 163: 5178-5182.
27. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
28. Ikawa, M., S. Yamada, T. Nakanishi, and M. Okabe. 1998. 'Green mice' and their potential usage in biological research. FEBS Lett. 430: 83-87.
29. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
30. Subleski, J. J., V. L. Hall, T. C. Back, J. R. Ortaldo, and R. H. Wiltrout. 2006. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver. Cancer Res. 66: 11005-11012.
31. Motohashi, S., A. Ishikawa, E. Ishikawa, M. Otsuji, T. Iizasa, H. Hanaoka, N. Shimizu, S. Horiguchi, Y. Okamoto, S. Fujii, et al. 2006. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 12: 6079-6086.
32. Suresh, M., G. Lanier, M. K. Large, J. K. Whitmire, J. D. Altman, N. H. Ruddle, and R. Ahmed. 2002. Role of lymphotoxin α in T-cell responses during an acute viral infection. J. Virol. 76: 3943-3951.
33. + T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol. 162: 2858-2866.
34. Singh-Jasuja, H., R. E. Toes, P. Spee, C. Munz, N. Hilf, S. P. Schoenberger, P. Ricciardi-Castagnoli, J. Neefjes, H. G. Rammensee, D. Arnold-Schild, and H. Schild. 2000. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191: 1965-1974.
35. Baker-LePain, J. C., M. Sarzotti, T. A. Fields, C. Y. Li, and C. V. Nicchitta. 2002. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J. Exp. Med. 196: 1447-1459.
36. Janetzki, S., D. Palla, V. Rosenhauer, H. Lochs, J. J. Lewis, and P. K. Srivastava. 2000. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int. J. Cancer. 88: 232-238.
37. + T cell primary responses and inhibition of secondary responses. J. Immunol. 174: 5382-5389.
38. Mueller, K. L., M. A. Daniels, A. Felthauser, C. Kao, S. C. Jameson, and Y. Shimizu. 2004. Cutting edge: LFA-1 integrin-dependent T cell adhesion is regulated by both Ag specificity and sensitivity. J. Immunol. 173: 2222-2226.
39. + T cells in the absence of IL-2/15 receptor β-chain expression or STAT5 activation. J. Immunol. 173: 3131-3139.
40. Carrio, R., O. F. Bathe, and T. R. Malek. 2004. Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment. J. Immunol. 172: 7315-7323.
41. + T cell contraction during primary infection. J. Immunol. 176: 507-515.
42. Goyos, A., N. Cohen, J. Gantress, and J. Robert. 2004. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96. Eur. J. Immunol. 34: 2449-2458.
43. Maniero, G. D., and J. Robert. 2004. Phylogenetic conservation of gp96-mediated antigen-specific cellular immunity: new evidence from adoptive cell transfer in Xenopus. Transplantation 78: 1415-1421.
44. Morales, H., A. Muharemagic, J. Gantress, N. Cohen, and J. Robert. 2003. Bacterial stimulation upregulates the surface expression of the stress protein gp96 on B cells in the frog Xenopus. Cell Stress Chaperones 8: 265-271.